Tag Archive for: Novo

Novo Holdings Portfolio Company Amolyt Pharma Enters into Definitive Agreement to be Acquired by AstraZeneca

/in

Deal value up to US$1.05 billion Novo Holdings co-led Series A financing in Amolyt, supported additional financings and is Amolyt’s largest investor Acquisition validates Novo Holdings’ strategy to identify and invest long term in high quality European biotech companies Copenhagen, Denmark – Novo Holdings A/S, a leading international life sciences investor, today announced that its portfolio […]

Read more

Researchers aim to advance quantum sensing to transform disease diagnosis and prevention

/in

With its unprecedented precision, quantum sensing holds the potential to reform biomedical and health sciences by improving the diagnosis and prevention of diseases. The Novo Nordisk Foundation has awarded a grant of DKK 150 million to establish the Copenhagen Center for Biomedical Quantum Sensing, under which an international research collaboration aims to develop novel quantum sensing […]

Read more

Raising awareness of Rare Disease

/in

Each year, Rare Disease Day aims to raise awareness of rare diseases and encourage positive change to patients’ lives. A disease is considered rare when it affects fewer than 1 in 2,000 people and there are 300 million people with rare diseases across the world.1 On Rare Disease Day 2023, we want to celebrate the […]

Read more

Novo Holdings Venture Investments team Newsletter

/in

The Novo Holdings Venture Investments team has published its 2023 newsletter today.   It is one of the largest and most active international life science venture investors with a track record of over 20 years investing in novel therapies.    For more information, please see Venture Investments 2023 Newsletter.    

Read more

Novo Holdings Portfolio Company ReViral to be Acquired by Pfizer

/in

Deal value of up to US$525 million Novo Holdings co-led ReViral Series B financing in 2018 ReViral developing novel antiviral therapies to treat RSV infections Validation of Novo Holdings’ strategy to identify and invest in high quality European biotech opportunities Copenhagen, Denmark – Novo Holdings A/S, a leading international life sciences investor, today announces that its […]

Read more